Related Experiment Video
Updated: Nov 26, 2025

11:27
Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio
Published on: August 28, 2018
22.7K
Delivery methods for CRISPR/Cas9 gene editing in crustaceans.
Sen Xu1, Thinh Pham1, Swatantra Neupane1
1Department of Biology, University of Texas at Arlington, Arlington, Texas 76019, USA.
Marine Life Science & Technology
|December 14, 2020
Summary
This review details CRISPR/Cas9 delivery methods for crustaceans, focusing on embryonic microinjection challenges and introducing novel techniques like ReMOT Control and electroporation for genomic editing.
Area of Science:
- * Crustacean genomics and gene editing technologies.
- * Molecular biology and genetic engineering.
Background:
- * CRISPR/Cas9 technology enables precise genomic editing.
- * Efficient delivery of CRISPR/Cas9 components is crucial for its application in crustaceans.
- * Embryonic microinjection is the primary method but presents technical difficulties.
Purpose of the Study:
- * To provide an up-to-date overview of CRISPR/Cas9 delivery methods in crustaceans.
- * To offer a technical guide for embryonic microinjection using examples from three species.
- * To introduce and discuss novel delivery techniques for crustacean gene editing.
Main Methods:
- * Review of existing literature on CRISPR/Cas9 delivery in crustaceans.
- * Detailed technical guide for embryonic microinjection in *Daphnia*, *Parhyale hawaiensis*, and *Exopalaemon carinicauda*.
- * Exploration of Receptor-Mediated Ovary Transduction of Cargo (ReMOT Control) and electroporation as alternative methods.
Main Results:
- * Embryonic microinjection is a widely used but technically demanding method for CRISPR/Cas9 delivery in crustaceans.
- * Specific challenges and protocols for microinjection in *Daphnia*, *P. hawaiensis*, and *E. carinicauda* are presented.
- * ReMOT Control and electroporation show potential as alternative, possibly more efficient, delivery systems.
Conclusions:
- * Advancements in CRISPR/Cas9 delivery are essential for expanding genomic editing applications in crustaceans.
- * Embryonic microinjection remains a key technique, with improved protocols enhancing its utility.
- * Emerging methods like ReMOT Control and electroporation offer promising avenues for future research and genetic manipulation in diverse crustacean species.
Related Concept Videos
CRISPR/Cas9 Genome Editing
1.1K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.1K
CRISPR
55.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
55.3K
CRISPR and crRNAs
18.2K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.2K

